BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	12,226	12,527	18,162	19,234	16,220	15,918
Market Cap Growth	2.74%	-31.03%	-5.57%	18.57%	1.90%	4.81%
Enterprise Value	11,385	12,199	18,132	19,051	16,229	15,917
Last Close Price	63.42	65.73	96.42	103.49	88.35	87.69
PE Ratio	23.74	29.35	108.34	135.87	-	18.64
Forward PE	14.10	17.86	38.98	39.00	85.79	75.56
PS Ratio	3.96	4.39	7.51	9.18	8.79	8.56
PB Ratio	2.01	2.21	3.67	4.18	3.80	3.88
P/TBV Ratio	2.18	2.44	4.10	4.73	4.41	4.56
P/FCF Ratio	14.73	25.70	290.28	350.06	77.63	-
P/OCF Ratio	13.41	21.87	114.04	109.34	53.26	186.47
PEG Ratio	0.74	0.72	1.07	0.86	2.66	1.75
EV/Sales Ratio	3.68	4.28	7.50	9.09	8.79	8.56
EV/EBITDA Ratio	14.34	18.30	62.49	121.62	481.22	1186.81
EV/EBIT Ratio	16.01	21.40	97.60	348.42	-	-
EV/FCF Ratio	13.68	25.03	289.80	346.74	77.67	-
Debt / Equity Ratio	0.10	0.11	0.23	0.24	0.26	0.28
Debt / EBITDA Ratio	0.75	0.93	3.73	6.58	23.56	43.10
Debt / FCF Ratio	0.73	1.30	18.12	20.38	5.38	-
Net Debt / Equity Ratio	-0.14	-0.09	0.01	-0.04	0.03	0.02
Net Debt / EBITDA Ratio	-1.10	-0.76	0.21	-1.10	3.25	4.92
Net Debt / FCF Ratio	-1.05	-1.03	0.96	-3.12	0.52	-2.28
Asset Turnover	0.43	0.41	0.37	0.34	0.31	0.35
Inventory Turnover	0.45	0.50	0.53	0.60	1.49	1.67
Quick Ratio	2.84	2.96	1.45	2.98	2.54	3.07
Current Ratio	4.83	5.33	2.51	4.67	4.16	4.76
Return on Equity (ROE)	9.07%	8.05%	3.51%	3.19%	-1.53%	23.63%
Return on Assets (ROA)	6.15%	5.15%	1.76%	0.55%	-0.78%	-1.09%
Return on Invested Capital (ROIC)	10.50%	8.84%	3.50%	1.18%	-1.74%	-2.46%
Return on Capital Employed (ROCE)	10.40%	8.90%	3.30%	0.90%	-1.40%	-1.70%
Earnings Yield	4.25%	3.41%	0.92%	0.74%	-0.40%	5.37%
FCF Yield	6.79%	3.89%	0.34%	0.29%	1.29%	-0.18%
Buyback Yield / Dilution	-2.10%	-2.67%	-1.39%	-3.34%	4.61%	-7.06%

Updated Oct 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q